Search results for "mutation."

showing 10 items of 2808 documents

The methylenetetrahydrofolate reductase C677T polymorphism and the risk of congenital heart diseases: a literature review

2014

Congenital Heart Diseases (CHDs) are the most commonand serious developmental anomaly and the leading non-infectious cause of mortality in the first year of life. Despite the advances in diagnosis and treatment, understanding of the developmental causes and aetiologies of CHDs has been limited. The hyperhomocysteinemia is one of the proved risk factors related to the occurrence of CHDs. The connection between cardiac defects, folate and hyperhomocysteinemia could be explained by a mutation in the methylenetetrahydrofolate reductase (MTHFR) gene. Indeed, the C677T MTHFR mutation produces a thermolabile variant of MTHFR with reduced enzymatic action resulting in higher plasma levels of homocy…

Methylenetetrahydrofolato reductasebiologyFolic acidC677T MTHFR mutationbusiness.industryHyperhomocysteinemiaBioinformaticsSettore MED/40 - Ginecologia E OstetriciaBirth defectMTHFR polymorphismMethylenetetrahydrofolate reductaseMTHFRbiology.proteinMthfr c677tMedicinebusinessCongenital heart disease
researchProduct

Direct Evidence for Viral Antigen Presentation during Latent Cytomegalovirus Infection

2021

Murine models of cytomegalovirus (CMV) infection have revealed an immunological phenomenon known as “memory inflation” (MI). After a peak of a primary CD8+ T-cell response, the pool of epitope-specific cells contracts in parallel to the resolution of productive infection and the establishment of a latent infection, referred to as “latency.” CMV latency is associated with an increase in the number of cells specific for certain viral epitopes over time. The inflationary subset was identified as effector-memory T cells (iTEM) characterized by the cell surface phenotype KLRG1+CD127−CD62L−. As we have shown recently, latent viral genomes are not transcriptionally silent. Rather, viral genes are …

Microbiology (medical)Adoptive cell transferAntigenicitylatent infectionTransgeneAntigen presentationCongenital cytomegalovirus infectionBiologymedicine.disease_causeEpitopeviral latencymedicineImmunology and AllergyMolecular BiologycytomegalovirusMutationGeneral Immunology and MicrobiologyBrief ReportRmedicine.diseaseVirologyantigen presentationInfectious Diseasesmemory inflation (MI)Medicineinflationary effector-memory CD8 T cells (iTEM)CD8Pathogens
researchProduct

Mutations in the rpoB and katG Genes Leading to Drug Resistance in Mycobacterium tuberculosis in Latvia

2002

ABSTRACT To characterize the genetic basis of drug resistance in Mycobacterium tuberculosis in Latvia, mutations involved in rifampin ( rpoB gene) and isoniazid ( katG gene) resistance in DNA from 19 drug-susceptible and 51 multidrug-resistant M. tuberculosis complex isolates were analyzed. The most frequent rpoB gene mutations found by the Line Probe assay were the S531L (14 of 34 isolates), D516V (7 of 34), H526D (4 of 34), and D516Y plus P535S (4 of 34) mutations. Direct sequencing of seven isolates with unclear results from Line Probe assay showed the presence of the L533P mutation and the Q510H plus H526Y (1 of 34) and D516V plus P535S (4 of 34) double mutations, neither of which has b…

Microbiology (medical)Antitubercular AgentsMicrobial Sensitivity TestsDrug resistanceGene mutationmedicine.disease_causeMycobacterium tuberculosischemistry.chemical_compoundBacterial ProteinsDrug Resistance BacterialmedicineHumansTuberculosisGenePlant ProteinsGeneticsMutationbiologyMycobacteriology and Aerobic ActinomycetesDNA-Directed RNA PolymerasesMycobacterium tuberculosisbiology.organism_classificationrpoBLatviaMolecular biologyDrug Resistance MultiplePeroxidaseschemistryMutationRestriction fragment length polymorphismDNAJournal of Clinical Microbiology
researchProduct

Mode of selection and experimental evolution of antiviral drugs resistance in vesicular stomatitis virus

2004

Abstract The possession of an antiviral resistance mutation benefits a virus when the corresponding antiviral is present. But does the resistant virus pay a fitness cost when the antiviral is absent? Would an evolutionary history of association between a genotype and a resistance mutation overcome this cost by changes compensating the harmful side-effect of resistance mutations? Are combined therapies more effective against the rise of resistant viruses or against evolutionary compensations? To explore all these questions, we took an experimental evolution approach. After selecting vesicular stomatitis virus (VSV) populations able to replicate under increasing concentrations of ribavirin an…

Microbiology (medical)GenotypeBiologyVirus ReplicationAntiviral AgentsMicrobiologyVirusVesicular stomatitis Indiana virusEvolution Molecularchemistry.chemical_compoundGenotypeDrug Resistance ViralRibavirinGeneticsMolecular BiologyEcology Evolution Behavior and SystematicsGeneticsExperimental evolutionDose-Response Relationship DrugRibavirinAntiviral therapyInterferon-alphaDrug SynergismResistance mutationbiology.organism_classificationVirologyInfectious DiseaseschemistryVesicular stomatitis virusMutationFitness costInfection, Genetics and Evolution
researchProduct

Influence of Haemophilus influenzae β-lactamase production and/or ftsI gene mutations on in vitro activity of and susceptibility rates to aminopenici…

2007

Microbiology (medical)Haemophilus InfectionsPenicillin binding proteinsmedicine.drug_classCephalosporinMicrobial Sensitivity TestsGene mutationmedicine.disease_causebeta-LactamasesMicrobiologyHaemophilus influenzaeAmp resistanceAmpicillinmedicineHumansPenicillin-Binding ProteinsPharmacology (medical)Mutationbusiness.industryGeneral MedicineHaemophilus influenzaeIn vitroCephalosporinsPhenotypeInfectious DiseasesSpainMutationAmpicillinbusinessAmpicillin Resistancemedicine.drugInternational Journal of Antimicrobial Agents
researchProduct

Recombination in viruses: Mechanisms, methods of study, and evolutionary consequences

2014

© 2014 Elsevier B.V. Recombination is a pervasive process generating diversity in most viruses. It joins variants that arise independently within the same molecule, creating new opportunities for viruses to overcome selective pressures and to adapt to new environments and hosts. Consequently, the analysis of viral recombination attracts the interest of clinicians, epidemiologists, molecular biologists and evolutionary biologists. In this review we present an overview of three major areas related to viral recombination: (i) the molecular mechanisms that underlie recombination in model viruses, including DNA-viruses (Herpesvirus) and RNA-viruses (Human Influenza Virus and Human Immunodeficien…

Microbiology (medical)Linkage disequilibriumMutation ratevirusesMutation rateReassortmentComputational biologyBiologymedicine.disease_causePopulation structureMicrobiologyArticleVirusEvolution MolecularReassortmentReassortant VirusesGeneticsmedicineLinkage disequilibriumAnimalsHumansRecombination rateMolecular BiologyGeneEcology Evolution Behavior and SystematicsRecombination GeneticGeneticsMutationRecombinationInfectious DiseasesVirus DiseasesMutationVirusesReassortant VirusesRecombination
researchProduct

Human toll-like receptor 4 mutations are associated with susceptibility to invasive meningococcal disease in infancy.

2006

Toll-like receptor 4 (TLR4) is required for efficient recognition of bacterial infections. We investigated an association between 2 TLR4 mutations (Asp 299 Gly and Thr 399 Ile) and meningococcal disease in 197 patients and 214 healthy controls by allele-specific real time polymerase chain reaction and direct sequencing. Although the allele frequency was not higher in the overall patient population, a significantly higher frequency in the 40 patients younger than 12 months of age (P = 0.007) was observed. We conclude that TLR4 mutations represent a risk factor for meningococcal disease in this age group.

Microbiology (medical)MaleMutation MissenseMeningococcal diseasemedicine.disease_causePolymerase Chain ReactionGene FrequencyMedicineHumansGenetic Predisposition to DiseaseRisk factorReceptorChildAllele frequencyAllelesToll-like receptorMutationbusiness.industryAge FactorsInfantDNASequence Analysis DNAmedicine.diseaseEuropeMeningococcal InfectionsToll-Like Receptor 4Infectious DiseasesReal-time polymerase chain reactionAmino Acid SubstitutionChild PreschoolPediatrics Perinatology and Child HealthImmunologyTLR4FemalebusinessThe Pediatric infectious disease journal
researchProduct

Mutation rate of bacteriophage ΦX174 modified through changes in GATC sequence context

2011

Bacteriophage ΦX174 has a relatively high mutation rate of 10⁻⁶ substitutions per nucleotide per strand copying. A thirty-fold reduction in the mutation rate was achieved by introducing seven GATC sequences in its genome. This motif allows for methyl-directed mismatch repair and is strongly avoided in nature by ΦX174 and other phages.

Microbiology (medical)Mutation rateGenome ViralDNA Mismatch RepairMicrobiologyGenomeEvolution MolecularBacteriophageGeneticsNucleotideMolecular BiologyEcology Evolution Behavior and SystematicsGeneticschemistry.chemical_classificationBase SequencebiologyDNA virusDNA Methylationbiology.organism_classificationInfectious DiseaseschemistrySingle Stranded DNA VirusDNA ViralMutationDNA mismatch repairBacteriophage phi X 174Infection, Genetics and Evolution
researchProduct

Reduction of nevirapine-driven HIV mutations by carbamazepine is modulated by CYP3A activity

2014

Item does not contain fulltext OBJECTIVES: The reduction in mother-to-child transmission of HIV-1 by single-dose nevirapine given at birth onset is achieved at the expense of de novo HIV-1 resistance mutations. In the VITA1 study, single-dose carbamazepine accelerated nevirapine elimination, but the accompanying trend towards fewer de novo HIV-1 mutations was statistically non-significant. METHODS: We investigated if the effect of carbamazepine was confounded by the individual variability in nevirapine metabolism and transport. RESULTS: Nine of 34 (26%) single-dose nevirapine-treated women had one or more nevirapine-associated resistance mutations, compared with 3 of 34 (9%) in the single-d…

Microbiology (medical)NevirapineCYP3AAnti-HIV AgentsHuman immunodeficiency virus (HIV)Mutation MissenseEndogenyHIV InfectionsPharmacologyBiologymedicine.disease_causeChemopreventionPregnancyDrug Resistance ViralmedicineClinical endpointCytochrome P-450 CYP3AHumansPharmacology (medical)NevirapinePharmacologyMutationCYP3A4Cytochrome P-450 CYP3A InducersCarbamazepinelnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4]Infectious DiseasesCarbamazepineTreatment OutcomeHIV-1Femalemedicine.drug
researchProduct

Resistance to clarithromycin and genotypes in Helicobacter pylori strains isolated in Sicily

2015

The resistance of Helicobacter pylori strains to clarithromycin is increasing in several developed countries and their association with a genetic pattern circulation has been variously explained as related to different geographical areas. In this study we have reported: the prevalence of the resistance of H. pylori, isolated in Sicily, to clarithromycin; the principal point of mutation associated with this resistance; and the more frequent association between resistance to clarithromycin and cagA, the EPIYA motif, and the vacA and oipA genes. Resistance to clarithromycin was detected in 25 % of cases, the main genetic mutation involved being A2143G. The cagA gene was present in 48 % of case…

Microbiology (medical)Settore MED/07 - Microbiologia E Microbiologia ClinicaVirulence FactorsMolecular Sequence Datamedicine.disease_causeMicrobiologyMicrobiology (medical); MicrobiologyMicrobiologyHelicobacter InfectionsBacterial ProteinsClarithromycinClarithromycinGenotypeDrug Resistance BacterialmedicinePrevalenceCagAHumansAlleleGeneSicilyMutationbiologyHelicobacter pyloriPrincipal pointGeneral MedicineHelicobacter pyloribacterial infections and mycosesbiology.organism_classificationVirologyAnti-Bacterial Agentsmedicine.drug
researchProduct